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Abstract
A number of RNA-containing viruses such as hepatitis C (HCV) and poliovirus (PV) that infect human beings and cause serious
diseases use a common mechanism for synthesis of viral proteins, termed internal ribosome entry site (IRES)-mediated translation.
This mode of translation initiation involves entry of 40S ribosome internally to the 50 untranslated region (UTR) of viral RNA. Cap-
dependent translation of cellular mRNAs, on the other hand, requires recognition of mRNA 50 cap by the translation machinery. In
this review, we discuss two inhibitors that specifically inhibit viral IRES-mediated translation without interfering with cellular cap-
dependent translation. We present evidence, which suggest that one of these inhibitors, a small RNA (called IRNA) originally
isolated from the yeast Saccharomyces cerevisiae, inhibits viral IRES-mediated translation by sequestering both noncanonical
transacting factors and canonical initiation factors required for IRES-mediated translation. The other inhibitor, a small peptide
from the lupus autoantigen La (called LAP), appears to block binding of cellular transacting factors to viral IRES elements. These
results suggest that it might be possible to target viral IRES-mediated translation for future development of therapeutic agents
effective against a number of RNA viruses including HCV that exclusively use cap-independent translation for synthesis of viral
proteins.
 2004 Federation of European Microbiological Societies. Published by Elsevier B.V. All rights reserved.
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Picornaviruses and flaviviruses encompass a large
variety of medically important human viruses, which
include those inducing poliomyelitis (poliovirus, PV),
infectious (hepatitis A) and chronic (hepatitis C, HCV)
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doi:10.1016/j.femsle.2004.03.045and encephalitis (coxsackieviruses). A common feature
of these diverse groups of viruses is the strategy they
employ for synthesis of viral proteins. While cellular
capped mRNAs are translated by a cap-dependent
‘‘scanning’’ mechanism, the naturally uncapped viral
RNAs use a cap-independent mechanism, which in-
volves internal entry of ribosome within the 50 un-
translated region (50UTR) of viral RNA, a process
termed internal ribosome entry site (IRES)-mediated
translation [1,2]. The observation that poliovirus RNA
is not translated efficiently in the yeast Saccharomyces
cerevisiae led to the identification and purification of a
small (60 nt) RNA capable of specifically inhibiting viral
IRES-mediated translation without interfering with
cellular cap-dependent translation [3,4]. The ability of
IRNA to discriminate between cap-dependent and cap-
independent translation led to investigations towards. Published by Elsevier B.V. All rights reserved.
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tween these two distinct modes of translation initiation
and exploiting this fundamental difference to target
hepatitis C virus (HCV) IRES-mediated translation as a
novel approach in developing antiviral agents against
HCV [5]. In this review, we will discuss the mechanism
by which IRNA and a small peptide derived from the
lulpus autoantigen La specifically inhibit viral IRES-
mediated translation.2. Viruses
Poliovirus is the prototype of a large variety of
medically important human and animal RNA viruses
(picornaviruses), which include those inducing common
cold (rhinovirus), infectious hepatitis (Hep. A), cox-
sackie disease (Coxsackie virus), encephalomyocarditis
(EMCV) and foot-and-mouth disease (FMDV) among
others. These viruses are non-enveloped. Hepatitis C
virus (HCV), on the other hand, is an enveloped RNA
virus belonging to the flaviridae family. HCV infection
frequently leads to chronic hepatitis, cirrhosis of the
liver, and hepatocellular carcinoma [6–8]. There is cur-
rently no effective therapy or vaccine available to HCV-
infected patients other than interferon (and ribavarin),
which is only effective in a small percentage of infected
patients. HCV has been a difficult virus to study due to
the lack of an appropriate tissue culture system and an
adequate, simple and low cost animal model. The RNA
transcribed in vitro from a cDNA clone of HCV has
been shown to be infectious when injected directly into
the livers of chimpanzees [9,10].
Although PV and HCV belong to different groups of
viruses, both contain single-stranded RNA genomes of
plus polarity of approximately 7500 (PV) and 9500
(HCV) nucleotides. Additionally, the strategy of gene
expression used by these viruses is remarkably similar at
the molecular level. Both PV and HCV plus-strand ge-
nomic RNAs are translated as polyproteins that are
proteolytically processed to mature structural and
functional proteins. Both viruses encode RNA-depen-
dent RNA polymerases that replicate the (+) strand
RNA through a negative-strand RNA intermediate.
Most importantly and pertinent to this review, both PV
and HCV RNA genomes are translated by a common
mechanism involving entry of ribosome to an internal
sequence within the 50 untranslated region (50UTR)
[2,11,12]. This mode of cap-independent translation is
different from the cap-dependent translation, which in-
volves 40S ribosome binding to the 50 terminal cap
structure on cellular mRNAs and scanning of the
mRNA until the appropriate AUG is encountered. This
fundamental difference could serve as a target for future
development of antiviral drugs effective against such
viruses as HCV [5,13,14].3. Eukaryotic translation
3.1. Cap-dependent translation
The majority of the capped eukaryotic mRNAs are
translated by the scanning mechanism in which the 43S
complex, consisting of a 40S subunit bound to eIF-2:
GTP: Met-tRNAi, is recruited at the capped 5
0 end of
mRNA [15]. The binding of the 43S complex to the
mRNA requires recognition of the mRNA 50 cap by
the cap binding protein complex, eIF-4F, consisting of
three subunits: eIF-4E (the cap-binding protein), eIF-
4A (an RNA helicase) and eIF-4G. The initiation
factor eIF-4G is a modular scaffolding protein, which
interacts simultaneously with eIF-4E, eIF-4A and sev-
eral other proteins including the polyadenylate-binding
protein (PABP). eIF-4G also interacts with ribosome
through eIF-3, a multisubunit initiation factor. eIF-4B
induced helicase activity of eIF-4A helps unwind the
mRNA secondary structure leading to formation
of single stranded region. eIF-4B then interacts with
the 18S rRNA to guide the 40S ribosomal subunit to
the single stranded region of the mRNA. Proteolysis of
eIF-4G subunit of eIF-4F is the cause of inactivation
of eIF-4F activity during poliovirus infection leading to
host cell translation shut-off [16]. eIF-5 induces hy-
drolysis of eIF-2 bound GTP leading to formation of
inactive eIF-2:GDP complex, which is recycled to eIF-
2:GTP by the guanine exchange factor, eIF-2B. The
joining of 60S ribosomal subunit is catalyzed by eIF-
5B leading to the formation of the 80S initiation
complex.
3.2. IRES-mediated translation
The development of bicistronic expression vectors
containing the PV and EMCV 50UTR located in the
intercistronic region led to the demonstration that this
region could confer internal initiation of translation on
mRNA [1,2]. Since then, functional IRES elements
have been identified in many other picornaviruses such
as HRV, FMDV, HAV, TMEV, and Coxsackie virus
[17]. The RNA genome of many other RNA viruses
including HCV, classical swine fever virus, murine
leukemia virus, simian immunodeficiency and cricket
paralysis viruses use IRES-mediated translation [17].
Although capped, some cellular mRNAs including
translation initiation factors, transcription factors,
oncogenes, growth factors, homeotic genes, and sur-
vival proteins contain IRES elements in their 50UTR
sequences that may allow them to be translated under
conditions when cap-dependent synthesis of proteins
may be impaired. It is generally thought that phos-
phorylation of eIF-4F complex under conditions of
stress, such as virus infection heat shock hypoxia,
could shut down the cap-dependent mode translation
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proteins encoded by these mRNAs can then be
achieved by IRES-mediated translation that may not
require the full participation of the subunits of the eIF-
4F complex.
Comparison of IRES elements of picornaviruses in-
dicates a lack of conservation of primary sequence with
the exception of a short polypyrimidine tract. The
structural requirements for translation initiation have
led to two main groups of IRES structures: one for
entero- and rhinoviruses, and the other for cardio- and
apthoviruses. A number of studies have shown the im-
portance of both RNA secondary and tertiary structures
in viral cap-independent translation [18–26]. It is thus
clear that the overall RNA structure of the IRES has an
active role in internal initiation.
3.3. Mechanism of IRES-mediated translation: require-
ment of canonical initiation factors (eIFs) in IRES-
mediated translation
The majority of viral IRES elements (with the
exception of HAV IRES) do not require eIF-4E, the
cap-binding protein for the 48S complex formation
(association of the 43S complex with mRNA). In ad-
dition, various viruses require different combination of
other canonical initiation factors. The canonical initi-
ation factors eIF-2, eIF-3, eIF-4B and eIF-4F were
found to be required for 48S complex formation with
the EMCV IRES [27]. In the 48S complex formation
assay, the cap-binding protein complex eIF-4F can be
replaced by a complex consisting of eIF-4A and the
central domain of eIF-4G (eIF-4G697–949) [28]. Con-
sistent with the interaction of eIF-4G697–949 with pi-
cornavirus IRES elements, internal initiation promoted
by these elements is efficient under conditions of eIF-
4G cleavage that leads to host cell translation shut-off
[16].
Similar analysis has shown that the 48S complex
formation by the HCV IRES element requires only eIF-
2: GTP: Met-tRNAi, eIF-3 and 40S subunits [29]. The
40S ribosome appears to interact with HCV RNA at
multiple sites including stems, loops, pseudoknots, as
well as the initiator AUG. Ribosomal protein S5/S9 as
well as eIF-2B and eIF-2c have been identified as co-
factors of HCV IRES-mediated translation [30,31].
Mutations of the IRES regions that constitute the
binding site for proteins are detrimental to IRES activity
[21].
The intergenic region of cricket paralysis virus
(CrPV) and the 50UTR element of PSIV (Plautia stali
intestinal virus), a virus closely related to CrPV, have
been shown to function as IRES elements [24,26]. Sur-
prisingly, the in vitro binding of 40S ribosome to the
CrPV IRES did not require any initiation factor. These
results suggest that the IRES itself substitutes func-tionally for the role played by the initiator tRNA in the
eIF-2:GTP:Met-tRNAi ternary complex.
3.4. Role of cellular transacting proteins in viral IRES-
mediated translation
Although the studies described above have shed light
on the minimum required canonical factors for viral
IRES-mediated translation, it is apparent that trans-
acting factors play an important role in modulating
IRES activity [32]. Cellular proteins such as La (lupus
autoantigen), PTB (polypyrimidine tract binding pro-
tein), PCBP2(poly rC binding protein), C23 (nucleolin)
and unr have been shown to interact with viral IRES
elements and stimulate IRES-mediated translation [33–
42]. It has been hypothesized that the transacting pro-
teins may act as ‘‘RNA chaperones’’ stabilizing IRES
secondary and tertiary structures to allow efficient
translation to take place [32]. In this review, we will
focus on the La protein and consequently the role of
other transacting proteins in cap-independent transla-
tion will not be discussed.
3.4.1. The La protein
La, a 52-kDa autoantigen in patients with systemic
lupus erythematosus, was one of the first cellular pro-
teins identified to interact with IRES-elements and
stimulate PV and HCV IRES-mediated translation
[34,35,42–44]. The majority of the La Protein is localized
in the nucleus and appears to be involved in small RNA
biogenesis including pre-tRNA maturation, stabilization
of nascent RNAs, nuclear retention of nascent tran-
scripts, and RNA pol III transcription termination [45].
However, cellular stress such as poliovirus infection
causes redistribution of the La protein from nucleus to
the cytoplasm possibly by removal of the C-terminal
nuclear localization signal by a viral protease [42,46].
The 408aa long La protein contains three putative
RNA recognition motifs (RRMs): the N-terminal 100
amino acids containing the highly conserved 60 amino
acid long ‘‘La motif’’ (called RRM1), followed by a
RNA recognition motif spanning amino acids 101–208
(RRM2), and RRM3 (amino acids 209–300). The C-
terminus of La is highly charged and is required for La’s
ability to enhance poliovirus RNA translation [47].
However, both the N- and C-terminal halves bind the
HCV 50UTR and are required for efficient translation
from the HCV IRES [35,48]. The N-terminal fragments
of the human protein, consisting of the La-motif and
RRM2 bind several RNA substrates with an affinity
comparable to that of the full-length protein. Although
the isolated ‘‘La motif’’ (amino acids 1–60) does not
bind RNA, even small deletions within the La motif
drastically decreases RNA binding affinity [49,50]. It is
thought that the La motif may increase the affinity of
RRM2 for RNA.
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4.1. IRNA sequesters a number of cellular transacting
proteins involved in viral IRES-mediated translation
Studies directed at understanding the mechanism by
which IRNA inhibits viral IRES-mediated translation
indicated that IRNA could sequester a number of cel-
lular RNA binding proteins thus making them un-
available to interact with the viral 50UTR. These
transacting proteins include the lupus autoantigen (La),
polypyrimidine tract binding protein (PTB), nucleolin,
and two other unidentified proteins having molecular
masses of 70 and 38 kDa. In addition to its ability to
inhibit viral IRES-mediated translation in vivo, repli-
cation of wt PV and a PV/HCV chimeric virus
containing the HCV IRES was drastically inhibited in
Huh-7 cells constitutively expressing IRNA [51,52].
IRNA has been shown to interact with the La protein
very strongly and the IRNA-mediated inhibition of PV
and HCV IRES-mediated translation can be reversed by
the exogenous addition of the purified La protein in
vitro. Additionally, the purified La protein forms aFig. 1. Structural alterations of IRNA lead to loss of translation inhibitory ac
models and enzymatic digestion maps of IRNA (A) and two mutants, mut
inhibition activity of IRNA and mutants. (D) UV cross-link analysis of RNA
mut1 IRNA (lanes 4–6), and mut2 IRNA (lanes 7–9) in the absence (lanes 1, 4
free extract. Reprinted with permission from Oxford University Press (Venkstable complex with the 50UTR of both HCV and PV.
Similarly, an RNA sequence (called SELEX RNA) that
was selected for high-affinity binding to the La protein
was found to sequester La and block HCV IRES-med-
iated translation [35]. Also, IFN treatment of cells leads
to selective inhibition of HCV IRES-mediated transla-
tion, which correlates to a reduced level of La protein
and transient expression of La in these cells completely
restored the selective inhibition of HCV translation [53].
Taken together, these results provide strong evidence
that La is needed for efficient translation of PV and
HCV RNA in vivo and that IRNA blocks viral trans-
lation by sequestering the La protein.
4.2. Structure–function relationship of IRNA: structural
alterations lead to loss translation inhibitory activity and
altered protein binding
In order to gain insight into how IRNA blocks IRES-
mediated translation, the secondary structure of IRNA
was determined. The secondary structure of IRNA
consists of two loops, a 7-base long stem, and a large
bulge region (Fig. 1A) [54]. Mutational analysis of
IRNA followed by secondary structure determinationtivity and altered protein binding. (A–C) Proposed secondary structure
1 (B) and mut2 (C). The numbers in parentheses indicate translation
–protein interaction was performed with 32P-labeled IRNA (lanes 1–3),
and 7) or presence of 30 lg (lanes 2, 5 and 8) and 60 and 9) HeLa cell-
atesan et al. (1999) Nucleic Acids Res. 27, 562–572).
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ondary structure was required for both IRNA’s ability
to bind cellular transacting proteins and inhibit viral
IRES-mediated translation. A mutant IRNA (mut1),
which lacks loop 2 (nt 36–43) due to a 3 nt substitution
(GCA to UUC), bound La extremely efficiently, but was
defective in interacting with p110 (nucleolin), p57 (PTB),
and p38 (Figs. 1B and D). This mutant is defective in
inhibiting IRES-mediated translation by 80% compared
to wt IRNA [54]. It is possible that loop 2 may not be
involved in La binding but may play an essential role in
binding other relevant proteins involved in IRES-med-
iated translation. Alternatively, the altered structure of
mut1 IRNA enables it to bind so much La that the
binding of other proteins is impaired. Indeed, such an
exclusionary role for La has been posited in a slightly
different context, where coating of mRNAs with La
has been proposed to prevent binding of ribosomal
initiation factors [54]. In the case of mut2 IRNA, the
swapping of complementary sequences (50-UUC-30 and
50-AAG-30) within the stem of IRNA alters its structure
due to formation of a new helix (Fig. 1C) [54]. Mut2
IRNA is 100% defective in inhibiting viral IRES-medi-
ated translation and highly defective in binding almost
all polypeptides, including La that normally interact
with IRNA (Fig. 1D). One possibility for this global
decrease of protein binding is that the structure is al-
tered so extensively that these proteins are no longer
capable of readily recognizing the RNA molecule.Fig. 2. Purification of HeLa cell proteins by IRNA affinity chromatograph
mock-Sepharose columns. Flow-through from the mock column (FTm, lane 1
the IRNA column (lanes 3–6) were analyzed by Northwestern blot using 32P I
translation activity by themselves. The right most lane (#7) is a positive cont
HeLa S10. (C) Translation of P2CAT in HeLa S10 (lane C) is stimulated by
fractions. (D) Cap-dependent translation of CAT is not stimulated significant
Translation of P2CAT is shown in the absence (lane 1) and presence of 0.5, 1.0
control. (F) Effect of Fb fraction on HCV IRES-mediated translation of luci
and CAT translation was monitored in limiting HeLa S10 translation extracts
(lane 2), 0.5 and 1 lg FT (lanes 3 and 4), 0.5 and 1 lg Fb (lanes 5 and 6), and 0
3), Fb (lane 4), Fc (lane 5) and Fd (lane 6) fractions were analyzed by Western
indicated. Western blot of each purified protein is shown in lane 7 for eachAlternatively, mut2 IRNA may be deficient in binding a
protein that recruits the other proteins; thus, a deficiency
in binding this protein leads to global decrease in protein
binding by mut2 IRNA. Taken together, these results
suggest that while interaction of La with IRES (or
IRNA) is important, additional factors are almost cer-
tainly involved in IRES-mediated translation.
4.3. Identification of IRES-specific translation factors by
IRNA affinity chromatography: IRNA interacts with both
canonical and non-canonical factors
In order to identify additional cellular factors in-
volved in IRES-mediated translation, HeLa translation
lysates were fractionated through an immobilized IRNA
affinity column. Bound proteins were eluted stepwise
with 25 mM (fraction a, Fa), 100 mM (Fb), 300 nM
(Fc), and 600 mM (Fd) KCl. The fractionated proteins
were examined by Northwestern blot using 32P IRNA as
probe. Most of the proteins that interact with IRNA
eluted in the Fb and Fc fractions (Fig. 2A). Passage of
the cell-free lysates through a control column having the
same matrix but not linked to IRNA, resulted in the
elution of almost all IRNA binding proteins in the flow-
through fraction (FTm, Fig. 2A). Proteins eluted in Fa,
Fb, Fc and Fd fractions from the mock column did not
bind the labeled IRNA probe (data not shown). In
contrast, the flow-through from the IRNA column had
no detectable 32P IRNA binding protein.y. (A) HeLa S10 proteins were purified through IRNA–Sepharose or
) and IRNA column (FT, lane 2) and fractions Fa, Fb, Fc and Fd from
RNA probe. (B) Various fractions as indicated on top did not have any
rol showing translation of P2CAT (PV IRES linked to CAT RNA) in
FTm (lane 2) and Fb fraction (lane 5) but not by FTm, Fa, Fc and Fd
ly by various fractions (lanes 2–7) compared to the control (lane 1). (E)
, 1.5 and 2.0 lg of Fb fraction, respectively (lanes 2–5). Lane 6 is buffer
ferase (Luc) from a bicistronic RNA (cap-CAT-HCV IRES-Luc). Luc
in the absence (lane 1) and presence of 1 lg FTm (lane 1, C), 1 lg FTm
.5 and 1 lg S10 9lanes 7 and 8). (G) FTm (lane 1), FT (lane 2), Fa (lane
blot using anti-La, anti-PTB, anti-PCBP2, anti-eIF-3 and anti-eIF-2 as
panel as positive control.
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translation
Different fractions from the IRNA affinity column
were tested for their ability to stimulate IRES-mediated
translation. Sub-optimal or limiting concentrations of
HeLa S10 extracts were used for in vitro translation
of P2CAT mRNA (containing PV 50UTR) and the effect
of addition of various fractions from the IRNA affinity
column were determined. The fractions by themselves (in
the absence of HeLa S10) had no P2CAT translation
activity (Fig. 2B). Addition of the flow-through (FT)
fraction from the IRNA column to limiting amount of
HeLa S10 did not stimulate IRES-mediated translation
significantly compared to the control (lanes 1 and 3,
Fig. 2C). As expected, the flow-through fraction (FTm)
from the mock column did stimulate both IRES-medi-
ated (8 fold) and cap-dependent (2 fold) translation (laneFig. 3. Interaction of IRNA with noncanonical and canonical factors. (A) Pu
silver stain. (B) A Northwestern blot of the same gel probed with 32P-labe
complex is shown using 32P-labeled IRNA and purified La, PTB and ribosom
stained gel of purified eIF-3 and eIF-3 are shown. (F) A Northwestern blot o
link analysis of RNA–protein complexes were performed using purified eIF-2, Figs. 2C and D). Among all the fractions from the
IRNA column, only the Fb fraction was found to stim-
ulate PV IRES-mediated translation 4-fold over the
control (lane 5, Fig. 2C). None of these fractions stim-
ulated cap-dependent translation significantly over the
control (Fig. 2D). A titration of the Fb fraction showed
up to 8-fold stimulation of IRES-mediated translation
(Fig. 2E). However, at higher concentrations of the Fb
fraction inhibition of translation was observed (lane 5,
Fig. 2E). The buffer alone had no significant effect on
translation (lane 7, Fig. 2E). Translation in reticulocyte
lysates of a bicistronic RNA showed that the Fb fraction
specifically stimulated HCV IRES-mediated synthesis of
luciferase almost to the level observed with the HeLa S10
fractions (Fig. 2F). These results strongly suggest that
factors retained by the IRNA affinity column are critical
for IRES-mediated translation.rified La, PTB and PCBP-2 were analyzed by SDS–PAGE followed by
led IRNA is shown. (C, D) UV cross-link analysis of RNA–protein
al salt wash (RSW) and S10 (C), and purified PCBP-2 (D). (E) A silver
f the same gel probed with 32P-labeled IRNA is shown. (G) UV cross-
3 and 32P-labeled HCV 50UTR, IRNA, and PV 50UTR as indicated.
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proteins as well as eIF-3 and eIF-2
To determine the level of protein factors required for
IRES-mediated translation, a series of Western blot
analyses were performed with various fractions recov-
ered from the IRNA- and mock-columns. As expected,
the flow-through fraction (FTm) from the mock-column
contained significant amounts of La, PTB, PCBP-2, eIF-
2 and eIF-3 (Fig. 2G, lane 1). However, the flow-
through fraction from the IRNA column was depleted
of most of these proteins except for some subunits of
eIF-3 (Fig. 2G, lane 2). A number of eIF-3 subunits
ranging from 66 to 170 kDa, the c subunit of eIF-2, PTB
and the La protein were detected in the Fb fraction
(Fig. 2G, lane 4). PCBP-2 was mostly present in the Fa
fraction (lane 3, Fig. 2G) although small amount of
PCBP-2 was detected in the Fb fraction (lane 4). These
results suggest that IRNA could block IRES-mediated
translation through interaction with not only the
transacting factors like La and PTB, but also canonical
initiations factors (eIF-2 and eIF-3) required for cap-
independent translation.
4.3.3. Purified La, PTB, eIF-3 and eIF-2 interact with
IRNA
The results obtained from IRNA affinity chromatog-
raphy were confirmed by direct binding of IRNA with
various purified proteins. Both UV cross-link and North-
western analyses demonstrated that purified La and PTB
bound very efficiently to IRNA (Figs. 3A, B and C). The
interaction of La and PTB with IRNA was specific as
shown by competition binding studies (4, 51 and data not
shown). However, in both RNA binding assays PCBP2
showed relatively weak interaction with IRNA (Figs. 3A
and D). The 170, 116, 110, and a doublet migrating at
approximately 66 kDa subunits of eIF-3 were cross-
linked to PV and HCV 50UTR and IRNA (Fig. 3G). In-
terestingly, PV 50UTR bound p170 very strongly, but
IRNA and HCV 50UTR bound this subunit of eIF-3
relatively weakly. Northwestern analysis also confirmed
the interaction of purified eIF-3 with IRNA (Fig. 3F).
Direct binding of purified eIF-2 to IRNA, PV and HCV
50UTR as measured by UV cross-link analysis was weak
(data not shown), although a significant amount of eIF-2
was found to interact with 32P-labeled IRNA by North-
western analysis (Fig. 3F). These results suggest that
IRNA interacts with at least two canonical translation
factors involved in IRES-mediated translation.5. Development of a novel peptide, which blocks viral
IRES-mediated translation
To examine the region of the La protein critical for
IRNA binding, we expressed and purified various de-
letion mutants of La and determined their ability tointeract with IRNA, HCV IRES and PV IRES. These
studies identified a highly conserved region of La (aa
11–28) within the N-terminus ‘‘La motif’’ (aa 1–60
within RRM1), which was absolutely necessary for La
binding to all three RNAs [55]. We synthesized a syn-
thetic peptide (called LAP for La peptide) correspond-
ing to amino acids 11–28 of La, which efficiently and
specifically blocked translation programmed by HCV
and PV IRES elements both in vivo and in vitro with-
out interfering with cap-dependent translation [55]. The
purified LAP peptide did not bind IRNA, HCV IRES
or PV IRES directly, but interfered with La binding to
all three RNAs. LAP-induced inhibition of IRES-
mediated translation in vitro could be completely re-
versed by addition of excess HeLa translation lysates
but not by excess 50UTR suggesting that LAP inhibits
viral translation by interacting with proteins rather than
the template RNA [55]. The amino acid sequence of
LAP, 11AALEAKICHQIEYYF GDF28, is highly con-
served in the La protein from a variety of species [55].
Single amino acid changes (the underlined amino acids
Y23 and F25 mutated to Q) in the LAP totally abro-
gated its translation inhibitory activity [55]. When the
Y23Q mutation was introduced into the full-length La
protein, the purified mutant protein was found to be
severely defective in binding HCV and PV IRES ele-
ments and was unable to stimulate IRES-mediated
translation from the viral IRES elements. Mutation of
the next tyrosine (Y24) to Q, however, did not alter La’s
ability to bind RNA and stimulate IRES-mediated
translation.
5.1. LAP enters cells efficiently and blocks HCV IRES-
mediated translation
We examined Lap’s ability to transduce cells by
incubating Huh-7 cells with FITC-labeled LAP. A
non-specific peptide (called NSP) derived from a differ-
ent region of the La protein was used as a negative
control in these experiments. We were able to demon-
strate that while LAP-FITC entered cells efficiently,
neither the NSP-FITC nor free FITC could enter cells
[55]. LAP appeared to be localized within the cytoplasm
of Huh-7 cells as confirmed by staining the nuclei with
Hoescht dye (Fig. 5). To determine the rate of LAP
entry into cells, Huh-7 cells were incubated with LAP-
FITC for various times and cells were then examined by
flow cytometry. We were surprised to find that nearly
100% of the cells had internalized LAP by 1.5 h [55].
We also found that the LAP-FITC entered cells at 4 C,
but at a slightly slower pace (30% slower), therefore
making it unlikely that the peptide was being endocy-
tosed. The entry of LAP into Huh-7 cells was confirmed
by a functional assay demonstrating that preincubation
of Huh-7 cells with LAP was sufficient to almost totally
block HCV IRES-mediated translation of firefly
Fig. 4. Cell entry and inhibition of HCV IRES-mediated translation in vivo by LAP. Huh-7 cells were incubated overnight with 5 lM of FITC-
labeled LAP (green) (A), or 5 lM unconjugated FITC (C), or 5 lM NSP-FITC (D). The cell membrane is stained (orange) with DiI. Cells were
visualized by confocal microscopy as described in Materials and Methods. (B) Huh-7 cells were incubated overnight with LAP-FITC (green) as
described above. The nuclei were stained with Hoeschst dye (blue). In this sample cell membrane was not stained with DiI. Huh-7 cells were pre-
incubated with various concentrations of LAP (E) or the HIV-1 Tat peptide (F). After 2.5 h, the cells were washed free of peptides and transfected
with the capped bicistronic RNA template (Cap-Rluc-HCV 50UTR-Luc). At 6 h post-transfection, the cell lysates were harvested and measured for
Renilla and firefly luciferase activity. Representative data from three separate transfections is shown. Reprinted with permission from the American
Society for Microbiology (Izumi et al. (2004) J. Virol. 78, 3763–3776).
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Cap-dependent translation of Renilla luciferase was not
significantly affected by LAP at lower concentrations. At
the highest concentration tested, there was a 40% re-5’ UTR
eIF-3
40S Ribosome
ORF
IRNAIRNA
LAPIRNA
//
AUG
eIF-2 : GTP: met-tRNA
ITAF
-3
40S Rib e
STOP  3’ UTR
Viral RNA
Fig. 5. Proposed mechanism for inhibition of viral IRES-mediated
translation by IRNA and LAP. The illustration depicts possible steps
where IRNA and LAP could interfere with binding of the 43S ribo-
somal complex to viral IRES elements. IRNA can sequester IRES
transacting factors (ITAFs) as well as canonical initiation factors eIF-2
and eIF-3 thus blocking interaction of viral RNA with the 40S ribo-
some. The La peptide (LAP) can block binding of ITAFs to viral
RNA. It is not known at present whether LAP also interferes with
interaction of viral IRES elements with canonical factors.duction in cap-dependent translation. An unrelated
peptide (HIV Tat peptide, which enters cells freely) did
not inhibit HCV IRES-mediated translation of Luc.
We also made single, double and triple amino acid
substitution mutants of LAP to determine which amino
acids were critical for LAP’s translation inhibitory ac-
tivity. Although several double and triple substitution
mutants completely lost translation-inhibitory activity,
an interesting observation was that the single mutant
Y23Q (#741) (but not Y24Q, # 633) was totally inactive
in blocking viral translation in vitro (Table 1 and [55]).
When the Y23Q mutation is introduced into full-length
La protein, there is almost total loss of both RNA
binding and translation stimulation by La [55]. Curi-
ously, almost all mutations that interfered with Lap’s
viral translation inhibitory activity also interfered with
its ability to enter cells (Table 1). Only one mutant (LAP
701) that had lost translation inhibitory activity could
still transduce cells, however, with much lower efficiency
compared to wt LAP.
Although translation from the HCV IRES has been
reported to require only eIF-2, eIF-3, GTP and met-
tRNA, a number of studies have shown a role of the La
protein in the translation of HCV and PV RNA. Our in
Table 1
Translation inhibition and cell entry of various LAP mutantse
Peptide Mutationa Activityc Cell entryd
LAP AALEAKICHQIEYYFGDF + +++
702 AALEAQICQQIEYYFGDF + +++
701 AALQAKICHQIQYYFGQF ) +
761 QQQEAKICHQIEYYFGDF + +
762 QQQEQKQCHQIEYYFGDF ) )
703 AALEAKICHQIEQQQGDQ ) )
771 AALEAKICHQIEYYQGDQ ) )
772 AALEAKICHQIEQQFGDF ) )
741 AALEAKICHQIEQYFGDF ) )
633 AALEAKICHQIEYQFGDF + +++
632 AALEAKICHQIEYYQGDF ) )
631 AALEAKICHQIEYYFGDQ ) NDb
aMutations are indicated by bold and underlined letters.
bND, not determined.
cActivity was assayed by the ability of the peptides to block p2CAT
translation.
dCell entry was determined by confocal microscopy of FITC-labeled
peptides.
eReprinted with permission from American Society of Microbiology
(Izumi et al. (2004) J. Virol. 78, 3763–3776).
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translation to almost the background level in vivo also
suggest a role of La in HCV mRNA translation. How-
ever, the possibility still exists that like IRNA, LAP is
able to interact with canonical factors eIF-2 and eIF-3.
Recent results from our laboratory have provided evi-
dence that suggest interaction of LAP with La and other
transacting factors that play important roles in IRES-
mediated translation [55]. This is suggested by the in-
ability of the purified La protein to completely reverse
the translation inhibitory effect of LAP; however, the
proteins present in HeLa lysates could completely re-
store translation induced by LAP [55]. Additionally, the
interaction of HCV and PV IRES with a number of
proteins including La and PTB in the HeLa lysates were
completely blocked by LAP(data not shown). Although
the nature of all the polypeptides that interact with LAP
are not known yet, it is quite possible that LAP could
block interaction of a number of transacting proteins as
well as eIF-2 and eIF-3 with the viral IRES element.
5.2. Acute toxicity and tissue distribution of LAP in
animals
To examine Lap’s potential as an IRES inhibitor in
animals, LAP was tested in rats for acute toxicity, tissue
distribution, and maximum concentration in various
tissues. LAP had no serious side effects when adminis-
tered to rats at 25 mg/kg body weight in terms of sur-
vival as well as abnormal pathology except for
development of rash in the paw in 10% of the experi-
mental animals. After a single intravenous injection of
LAP at 10 mg/ml body weight, 50–60% of the dosed
LAP was found to localize to the liver of rats and re-mained there for at least 6 h (data not shown). At 24 and
48 h post injection, approximately 13% and 1% re-
mained in the liver. The maximum concentration of
LAP in the liver was found to be 160 lg/g. Currently
we are testing suitable viruses that use IRES-mediated
translation as well as infect liver cells in rats (or mice).
Identifying such viruses will help determine the efficacy
of LAP in mice.6. Concluding remarks
The chance discovery that poliovirus RNA is not
translated in the yeast S. cerevisiae has led to the dis-
covery of a naturally occurring yeast RNA (IRNA)
capable of specifically inhibiting viral IRES-mediated
translation. The studies leading to understanding the
mechanism of IRNA has consequently resulted in the
development of another IRES-specific peptide inhibitor
(LAP). Initial preclinical studies have shown that LAP
has excellent potential to be developed as an inhibitor of
HCV protein synthesis. LAP may also have applications
in other human diseases that involve synthesis of cellular
proteins by IRES-mediated translation. For example,
the mRNA encoding the angiogenic factor, vascular
endothelial growth factor (VEGF), is translated in an
IRES-dependent fashion under hypoxic conditions in-
duced by rapidly growing tumors [56]. Although the
VEGF mRNA is capped, cap-dependent translation
most probably does not contribute to VEFG synthesis
in a fast-growing tumor due to phosphorylation (and
inactivation) of the cap-binding protein under hypoxic
condition. Thus, the IRES inhibitors LAP/IRNA
should, in principle, inhibit formation of the VEGF
protein ultimately leading to retarded tumor growth.
Since LAP readily enters cells and appears to be rela-
tively stable in vivo (animals), its efficacy in blocking
formation of new blood vessels can be directly tested by
injecting LAP into growing tumors. Future studies into
the three-dimensional structure of LAP and IRNA may
lead to design of novel therapeutic molecules more ef-
fective in inhibition of viral/cellular IRES-mediated
translation.
Apart from the usefulness of IRNA and LAP in
identifying and understanding the mechanisms by which
transacting proteins participate in the IRES-mediated
translation in mammalian cells, we have just begun to
use these molecules to examine IRES-mediated trans-
lation in the yeast S. cerevisiae. Initial studies have
identified four yeast proteins that interact strongly with
IRNA. One of these proteins has been identified as
Zuotin (Zuo1), a DnaJ molecular chaperone homolo-
gous to mammalian hsp40. Our recent studies using
Zuo1 knock out yeast have shown that Zuo1 specifically
stimulate IRES-mediated translation in yeast. The three
other yeast proteins that interact with IRNA have also
198 A. Dasgupta et al. / FEMS Microbiology Letters 234 (2004) 189–199been identified and all three appear to be involved in
protein synthesis. Future studies will determine whether
these proteins also participate in IRES-mediated trans-
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